Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | AHCY | P23526 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | JAK2 | O60674 | 4/20 | 0.37 |
| ▸ | JAK3 | P52333 | 4/20 | 0.37 |
| ▸ | P2RY1 | P47900 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAP2K1 | Q02750 | 5/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19036512 | 0.84 | P2RY1 (0.37) | P2RY1 | |
| SCHEMBL18175167 | 0.80 | LMNA (0.37) | LMNAADORA2AP2RY1 | |
| SCHEMBL19036600 | 0.79 | YTHDC1 (0.37) | P2RY1 | |
| SCHEMBL30800978 | 0.78 | POLB (0.38) | POLBSMN1; SMN2LMNAAHCYADORA2A | |
| SCHEMBL9010469 | 0.77 | IKBKB (0.36) | SMN1; SMN2ADORA2AP2RY1 | |
| SCHEMBL10280149 | 0.75 | TRPA1 (0.36) | P2RY1 | |
| SCHEMBL27967273 | 0.71 | KMT2A (0.42) | P2RY1 | |
| SCHEMBL29188195 | 0.70 | POLB (0.36) | POLBSMN1; SMN2LMNAAHCYADORA2A | |
| SCHEMBL20079664 | 0.69 | ULK1 (0.40) | — | |
| SCHEMBL9602894 | 0.64 | TLR7 (0.51) | POLBSMN1; SMN2LMNAAHCYADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117865896-A | Dihydroxypropyl theophylline impurity, preparation and detection method thereof | 江苏东科康德药业有限公司 | 2024-04-12 | — | — | CN | disclosed |